NATCO Pharma Limited (NSE:NATCOPHARM)

NATCO Pharma Revenue

In the fiscal year ending March 31, 2026, NATCO Pharma had annual revenue of 40.78B INR, down -7.98%. NATCO Pharma had revenue of 7.39B in the quarter ending March 31, 2026, a decrease of -39.59%.

• Revenue: 40.78B
• Revenue Growth: -7.98%
• P/S Ratio: 3.90
• Revenue / Employee: 9.71M
• Employees: 4,199
• Market Cap: 159.23B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	40.78B	-3.54B	-7.98%
Mar 31, 2025	44.32B	4.30B	10.74%
Mar 31, 2024	40.02B	12.94B	47.76%
Mar 31, 2023	27.09B	7.62B	39.17%
Mar 31, 2022	19.46B	-1.10B	-5.35%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 20, 2026

Data Sources Report a data error